Operating

Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital

West Pharmaceutical Services Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital increased by 2409.8% to $102.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 103000.0%, from -$100.00K to $102.90M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalHigher is better
VolatilityVolatile
First reportedQ1 2024
Last reportedQ1 2026Apr 23, 2026

How to read this metric

A positive value indicates cash generation through efficient working capital management, while a negative value indicates cash tied up in operations.

Detailed definition

This metric aggregates changes in working capital components, such as accounts receivable, inventory, and accounts payab...

Peer comparison

Highly comparable across all sectors; a key indicator of operational efficiency and cash conversion cycle health.

Metric ID: operating_increase_decrease_in_operating_capital

Historical Data

5 periods
 Q1 '24Q3 '24Q1 '25Q2 '25Q1 '26
Value$34.60M$100.00K-$100.00K$4.10M$102.90M
QoQ Change-99.7%-200.0%>999%>999%
YoY Change-100.3%>999%
Range-$100.00K$102.90M
CAGR+197.4%
Avg YoY Growth>999%
Median YoY Growth>999%
Current Streak2 quarters growth

Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital at Other Companies

Frequently Asked Questions

What is West Pharmaceutical Services's adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital?
West Pharmaceutical Services (WST) reported adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital of $102.90M in Q1 2026.
How has West Pharmaceutical Services's adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital changed year-over-year?
West Pharmaceutical Services's adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital increased by 103000.0% year-over-year, from -$100.00K to $102.90M.
What does adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital mean?
The net cash impact of changes in day-to-day working capital items.